Engitix Engitix Therapeutics is a company offering a human extracellular matrix (ECM)-based discovery platform. | |||
Founding Date | Founding Date 2018 | Founding Date 2013 | Founding Date 2016 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Emeryville, US HQ | Locations London, GB HQ New York, US New York, US | Locations Cambridge, US HQ London, GB London, GB |
Employees | Employees 223 | Employees 19 | Employees 542% increase |
Funding | |||
Total funding raised | Total funding raised $ 74.9m | Total funding raised N/A | Total funding raised $ 6.4m |

Eleusis is a company developing the therapeutic potential of serotonin 2A receptor agonists.
View companyEngitix Therapeutics is a company offering a human extracellular matrix (ECM)-based discovery platform.
View company